Supportive care for the prevention of disease recurrence/progression following peri‐implantitis treatment: A systematic review

Abstract

AbstractObjectivesThis systematic review aimed to evaluate the efficacy of supportive care provision, frequency and protocol in patients treated for peri‐implantitis, as reported in prospective and retrospective studies of at least 3‐years duration.Materials and MethodsA systematic search of three electronic databases was undertaken up to 21 July 2022 and supplemented by hand‐search to identify studies that included participants treated for peri‐implantitis and followed for at least 3 years. Owing to high heterogeneity, a meta‐analysis was not appropriate, and therefore, data and risk of bias were explored qualitatively. PRISMA guidelines for reporting were followed.ResultsThe search identified 2596 studies. Of 270 records selected during screening, 255 were excluded through independent review and 15 studies (10 prospective and 5 retrospective, with at least 20 patients) were retained for qualitative assessments. Study designs, population characteristics, supportive care protocols and reported outcomes varied markedly. Thirteen of the 15 studies had low risk of bias. Supportive peri‐implant care (SPIC) following different surgical peri‐implantitis treatment protocols and with recall intervals varying between 2 months and annually resulted in peri‐implant tissue stability (no disease recurrence or progression) ranging from 24.4% to 100% at patient level and from 28.3% to 100% at implant level. Sevenhundred and eighty‐five patients with 790 implants were included in this review.ConclusionsProvision of SPIC following peri‐implantitis therapy may prevent disease recurrence or progression. Insufficient evidence is available to identify (i) a specific supportive care protocol for secondary prevention of peri‐implantitis, (ii) the effect of adjunctive local antiseptic agents in the secondary prevention of peri‐implantitis and (iii) the impact of frequency of supportive care measures. Prospective, randomised, controlled studies designed to evaluate supportive care protocols are needed in future.